| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥526.2B | ¥476.0B | +10.5% |
| Operating Income | ¥66.8B | ¥60.0B | +11.3% |
| Ordinary Income | ¥73.9B | ¥64.1B | +15.2% |
| Net Income | ¥47.7B | ¥41.3B | +15.5% |
| ROE | 9.4% | 8.3% | - |
FY2026 Q3 results show balanced growth across all profit levels. Revenue reached 526.2B yen (YoY +10.5%), Operating Income 66.8B yen (+11.3%), Ordinary Income 73.9B yen (+15.2%), and Net Income 47.7B yen (+15.5%). Operating margin improved to 12.7% (+0.1pt YoY) driven by selling, general and administrative expense efficiency gains of 0.45pt, offsetting a 0.3pt decline in gross margin to 21.7%. Non-operating gains including foreign exchange gains of 310M yen and interest income contributed to ordinary income growth exceeding operating income growth. Progress toward full-year guidance stands at 75% for revenue, 79% for operating income, and 90% for net income, indicating solid trajectory toward targets of 70.0B yen revenue, 8.5B yen operating income, and 5.3B yen net income.
[Profitability] ROE of 8.2% positions near the lower bound of healthy range, decomposed into net profit margin 8.0%, asset turnover 0.642x, and financial leverage 1.61x. Operating margin of 12.7% improved 0.1pt YoY as SG&A expense ratio compression of 0.45pt to 9.0% offset gross margin contraction of 0.3pt to 21.7%. Net profit margin expansion was constrained by elevated tax burden at effective rate of approximately 43-44%. Operating leverage remains positive with revenue growth of 10.5% outpacing SG&A expense growth of approximately 5.6%. [Cash Quality] Cash and deposits of 28.2B yen provide 3.50x coverage of short-term debt of 8.1B yen. Interest coverage ratio stands at approximately 252x, reflecting minimal interest burden of 265M yen against operating income of 66.8B yen. [Investment Efficiency] Total asset turnover of 0.642x remains moderate as asset base expanded YoY, with cash and investment securities accumulation partially restraining turnover velocity. Intangible asset growth of 35.4% to 3.1B yen and property, plant and equipment expansion signal ongoing platform and capacity investments. [Financial Health] Equity ratio of 62.0%, current ratio of 170.0%, and quick ratio of 169.5% demonstrate robust solvency and liquidity. Debt-to-equity ratio of 0.16x and debt-to-capital ratio of 13.7% reflect conservative capital structure. Contract liabilities of 4.9B yen provide revenue visibility.
Cash and deposits increased 2.1B yen YoY to 28.2B yen, reflecting earnings accumulation and balance sheet funding adjustments. Short-term borrowings surged 7.9B yen to 8.1B yen, representing a significant shift in funding composition toward short-term debt with short-term debt ratio reaching 100%, though covered 3.50x by cash reserves. Working capital structure shows accounts receivable at 6.8B yen remaining proportionate to revenue scale, while contract liabilities of 4.9B yen support favorable cash conversion characteristics inherent in the advance payment business model. Intangible assets increased 820M yen and other property, plant and equipment expanded 3.5B yen, indicating capital deployment into growth infrastructure and IT platforms that will generate future depreciation and amortization charges. Investment securities declined 100M yen to 8.1B yen. The combination of robust cash position, minimal interest burden of 265M yen, and interest coverage of 252x indicates strong liquidity resilience despite near-term rollover requirements on short-term borrowings.
Ordinary income of 73.9B yen versus operating income of 66.8B yen reflects net non-operating contribution of approximately 7.1B yen. Non-operating income totaling approximately 8.5B yen comprises foreign exchange gains of 310M yen, interest and dividend income, and equity method investment gains as primary components. Non-operating income represents approximately 1.6% of revenue. Interest expense of 265M yen remains modest relative to operating income. The improvement in ordinary income growth to 15.2% compared to operating income growth of 11.3% indicates material contribution from financial and non-recurring items, warranting attention to sustainability of non-operating gains, particularly foreign exchange effects. The elevated tax burden coefficient of 0.565, corresponding to an effective tax rate in the 43-44% range, significantly exceeds standard statutory rates and suggests limited tax efficiency optimization or presence of non-deductible items. Core operating earnings quality remains sound with operating margin expansion and positive operating leverage, though non-operating dependency and tax drag warrant monitoring.
Short-term borrowings surged 7.9B yen to 8.1B yen with short-term debt ratio reaching 100%, creating refinancing and rollover risk if credit conditions tighten or cash conversion weakens, despite current 3.50x cash coverage providing near-term buffer. Elevated effective tax burden at approximately 43-44% (tax burden coefficient 0.565) materially constrains net margin expansion and ROE improvement, with lack of tax efficiency optimization limiting earnings potential by approximately 10-15% relative to normalized tax rates. Ordinary income growth of 15.2% exceeding operating income growth of 11.3% reflects 310M yen foreign exchange gain dependency, exposing earnings volatility to currency fluctuations particularly yen depreciation reversals.
[Industry Position] (Reference - Proprietary Analysis) Profitability: Operating margin 12.7% exceeds industry median 8.2% (75th percentile positioning), demonstrating superior operational efficiency within healthcare services sector. Net profit margin 8.0% surpasses industry median 5.7% (above 75th percentile), though tax burden constrains margin relative to operational performance. ROE 8.2% falls below industry median 9.7% (below 50th percentile), with gap attributable to conservative 1.61x financial leverage versus sector norm and elevated tax drag offsetting strong operating margins. Financial Health: Equity ratio 62.0% exceeds industry median 49.0% (above 75th percentile at 66.3%), reflecting conservative capitalization. Current ratio 170.0% falls below industry median 206.0% (below 50th percentile at 153.0%) primarily due to recent short-term borrowing increase, though still within healthy range. Net debt position benefits from cash exceeding gross debt. Growth: Revenue growth 10.5% aligns with industry median 9.5% (50th-75th percentile range), indicating sector-consistent expansion trajectory. Efficiency: Asset turnover and capital efficiency metrics remain moderate relative to operating margin strength, suggesting opportunity for balance sheet optimization. (Industry: Healthcare Services, N=44 companies, Comparison: FY2025-Q3 period, Source: Proprietary analysis)
Operating fundamentals demonstrate healthy execution with revenue growth of 10.5% paired with operating margin expansion to 12.7%, positioning above industry median efficiency levels while maintaining sector-typical growth rates. The positive operating leverage evidenced by SG&A ratio compression of 0.45pt to 9.0% despite gross margin headwinds suggests scalable cost structure and operational discipline. Progress of 75-79% toward full-year guidance across revenue and profit metrics indicates realistic target achievement probability. However, earnings quality exhibits two structural constraints requiring monitoring: first, the 43-44% effective tax rate materially exceeds industry norms and directly limits ROE to 8.2% despite operating margin leadership, suggesting 100-200bp ROE upside potential from tax optimization; second, the 310M yen foreign exchange gain contribution to 15.2% ordinary income growth versus 11.3% operating income growth indicates non-operating dependency that may not recur. The balance sheet transformation toward short-term debt reliance, with borrowings surging 7.9B yen to constitute 100% of debt structure, marks a notable shift from prior conservative posture, though 3.50x cash coverage and 252x interest coverage maintain adequate safety buffers. The 3.1B yen intangible asset base growing 35.4% and property, plant and equipment expansion signal ongoing platform investment cycle that should support medium-term growth but will elevate depreciation charges. Contract liabilities of 4.9B yen and advance payment business model characteristics provide revenue visibility supporting guidance confidence. The combination of above-median operating margins, at-median revenue growth, and below-median ROE positions the company as an operationally efficient but financially conservative player with tax efficiency and capital structure optimization representing key value enhancement levers.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.